1. Biomarkers for Early Diagnosis of Ovarian Carcinoma.
- Author
-
Manasa G, Mascarenhas RJ, Shetti NP, Malode SJ, and Aminabhavi TM
- Subjects
- Algorithms, Biomarkers, Tumor, Carcinoma, Ovarian Epithelial, Early Detection of Cancer, Female, Humans, Proteins, WAP Four-Disulfide Core Domain Protein 2, CA-125 Antigen, Ovarian Neoplasms diagnosis
- Abstract
The leading cause of gynecological cancer-related morbidity and mortality is ovarian cancer (OC), which is dubbed a silent killer. Currently, OC is a target of intense biomarker research, because it is often not discovered until the disease is advanced. The goal of OC research is to develop effective tests using biomarkers that can detect the disease at the earliest stages, which would eventually decrease the mortality, thereby preventing recurrence. Therefore, there is a pressing need to revisit the existing biomarkers to recognize the potential biomarkers that can lead to efficient predictors for the OC diagnosis. This Perspective covers an update on the currently available biomarkers used in the triaging of OC to gain certain insights into the potential role of these biomarkers and their estimation that are crucial to the understanding of neoplasm progression, diagnostics, and therapy.
- Published
- 2022
- Full Text
- View/download PDF